Published May 20, 2013
Scientists have long known that Crohn’s patients – even when they are in remission – suffer from fatigue and low quality of life.
So when Tara Raftery, a research dietitian at Trinity College in Dublin, Ireland, who works specifically on Crohn's disease, saw emerging evidence suggesting a lack of vitamin D may alter muscle function and strength she decided to set up a study investigating the possible effects of vitamin D on fatigue and quality of life in Crohn’s patients.
Crohn’s disease is an inflammatory condition with no known cure and often causes diarrhea, abdominal pain, mouth sores and joint pain. Patients often feel extremely fatigued – either from the extensive medicines they have to take or from the disease itself.
“Some research has suggested that vitamin D supplementation might influence muscle strength and quality of life,” Raftery told FoxNews.com. “But this was yet to be shown in Crohn’s disease.”
Raftery said she and her doctorate supervisor, Maria O’Sullivan, performed a three-month study, where half of the participants – all Crohn’s patients who were in remission – were given vitamin D supplements and the other half were given a placebo.
“So at the start of the study, we measured their baseline vitamin D levels,” Raftery said. “We also measured fatigue and quality of life by using validated questionnaires, and we measured hand-grip strength – this gave us a proxy measure of their muscle strength.”
At the end of three months, the researchers repeated those measures.
“What we found, was in the participants who received the vitamin D supplements (of 2,000 International Units per day), their hand-grip strength was significantly stronger than those who took the placebo,” Raftery said. “We measured both the dominant and non-dominant hand grip strength at baseline. After three months, those who had received the vitamin D supplement had significantly stronger hand grip, in both hands, compared to those who were randomized to the placebo pill.”
Raftery said they also found the patients who had vitamin D levels of above 30 ng/ml had a significantly higher quality of life compared to those patients who had less than that and those patients taking the placebo.
“In terms of fatigue, what we found was that when the levels were 30ng/ml or more, the patients reported significantly less physical fatigue, as well as mental and general fatigue,” Raftery said.
Raftery said these findings are the first to suggest the potential benefits of vitamin D supplementation in Crohn’s patients to improve muscle function, fatigue and quality of life.
While more studies need to be done, researchers are hopeful. Raftery is currently conducting a larger study – containing more participants studied over a one-year period - to confirm her initial findings.
“What I would recommend, is that patients with Crohn's disease discuss supplementation with their doctor and also have their levels rechecked about three months after supplementation begins," Raftery said. “Vitamin D supplementation is safe for most people, but not everyone . . . mega-doses should be avoided and many countries have set upper limits of 2,000-4,000 International Units a day for adults."
Raftery will present her findings at Digestive Disease Week in Orlando during the week of May 20.